OPERATOR: Good afternoon, thank you for standing by. Welcome to CDC’s briefing. Today’s conference is being recorded. If you have any objection, you may disconnect at this time. Your lines are in listen only mode until the question and answer session. At that time you may hit star followed by the question. It is now […]
Good article in the Journal of the Neurological Sciences June 16, 2020 In this systematic review, we will discuss the evidence on the occurrence of central nervous system (CNS) involvement and neurological manifestations in patients with COVID-19. Results Through the search strategy, we could identify two articles about neurological involvement by COVID-19. One of these publications […]
As of April 5, 2022, the U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for GSK-Vir Biotechnology’s sotrovimab monoclonal antibody treatment. It is important to note Sotrovimab is no longer authorized for use within the U. S. The full FDA press release can be read at FDA updates Sotrovimab emergency use […]
What is already known about this topic? Currently, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are recommended for U.S. adults. Recommendations vary by age and risk groups. What is added by this report? On October 20, 2021, the Advisory Committee on Immunization Practices recommended 15-valent PCV (PCV15) or […]
FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results equal to or better than the reduction of MRSA. This research is being assessed analytically and VESTEX® does intend to seek FDA clearance for specific claims […]
Some COVID-19 rapid antigen home test kits are much easier to use than others, according to an analysis by ECRI, an independent, nonprofit patient safety organization. ECRI evaluated seven rapid COVID-19 antigen tests available for purchase online and in retail stores since December. None of the tests were rated as “excellent” in terms of usability and some […]
As of August 27, 2019, 215 possible cases of severe pulmonary disease associated with the use of electronic cigarette, or e-cigarette, products, have been reported by 25 states and additional pulmonary illnesses are under investigation. Source link
Today the U.S. Centers for Disease Control and Prevention (CDC) has activated its Emergency Operations Center (EOC) to enhance the inter-agency response to the current investigation into cases of lung injury associated with e-cigarette product use, or vaping. “CDC has made it a priority to find out what is causing this outbreak of e-cigarette or […]
CDC is currently investigating cases of respiratory illnesses in the states of California and Texas. The individuals who have become ill are between the ages of 7 and 55. 63% of the cases are male. Treatment for anyone suspected of having this illness (swine influenza) are oseltamivir and zanamivr. Symptoms of the illness include cold […]
InCo & Associates Quarterly Newsletter Fall marks the beginning of the Influenza season. For long-term care facilities this signifies numerous flu shots for residents and staff members. Influenza is a common respiratory illness affecting thousands of people worldwide each year. Unfortunately, influenza may be lethal for individuals over the age of 65. Therefore, annual influenza […]